Pediatric and Maternal Health Product Development

Division Director: Lynne Yao, M.D.
Deputy Director: John Alexander, M.D., MPH

The Division of Pediatric and Maternal Health (DPMH) is located in the Office of New Drugs.  DPMH oversees quality initiatives which promote and necessitate the study of drug and biological products in the pediatric population and to improve pregnancy and lactation-related information in product labeling.

What is DPMH’s Role?

To collaborate to develop clinically relevant, evidence-based labeling and other communications that facilitate informed use of medicines in children, pregnant females, lactating females, and females and males of reproductive potential.

Contact DPMH

Food and Drug Administration
Center for Drug Evaluation and Research
Office of New Drugs
10903 New Hampshire Avenue
Silver Spring, MD 20993
Main Line: 301-796-2200   
Fax: 301-796-9744

Page Last Updated: 06/27/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English